Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
Locally advanced gastric cancer with a high risk of intraperitoneal progression is characterized by poor prognosis. After radical surgery, most patients die during the first two years post-operation as a result of disease progression. The prevailing type of progression and the leading cause of death...
Main Author: | Yarema Roman |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-12-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/cipms-2017-0036 |
Similar Items
-
Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01) -
Treatment of Krukenberg tumor with hyperthermic intraperitoneal chemotherapy: A report of three cases
by: Li-Yung Chen, et al.
Published: (2016-01-01) -
Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?
by: Rau Beate, et al.
Published: (2017-12-01) -
The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Natasha Leigh, et al.
Published: (2020-07-01)